Seroprotection rates/Vaccine response rates | GMC | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DTPw-HBV/Hib 2.5 [Kft] | DTPw-HBV/Hib | DTPw -HBV/Hib2.5 | DTPw-HBV/Hib 2.5 [Kft] | DTPw-HBV/Hib | DTPw -HBV/Hib2.5 | |||||||||||
Time point | N | % | 95% CI | N | % | 95% CI | N | % | 95% CI | Value | 95% CI | Value | 95% CI | Value | 95% CI | |
Diphtheria ≥0.1 IU/ml (or ≥0.016 IU/ml by neutralization assay) | Pre | 93 | 31.2 | 22.0-41.6 | 89 | 34.8 | 25.0-45.7 | 85 | 24.7 | 16.0-35.3 | 0.086 | 0.070-0.105 | 0.082 | 0.069-0.097 | 0.076 | 0.063-0.093 |
Post | 93 | 100 | 96.1-100 | 89 | 98.9 | 95.9-100 | 85 | 100 | 95.8-100 | 2.89 | 2.30-3.64 | 1.76 | 1.41-2.19 | 1.65 | 1.36-2.02 | |
Tetanus ≥0.1 IU/ml | Pre | 93 | 100 | 96.1-100 | 89 | 100 | 95.9-100 | 85 | 100 | 95.8-100 | 1.950 | 1.561-2.437 | 2.416 | 1.991-2.932 | 2.112 | 1.751-2.548 |
Post | 93 | 100 | 96.1-100 | 89 | 100 | 95.9-100 | 85 | 100 | 95.8-100 | 4.74 | 3.78-5.95 | 2.82 | 2.32-3.45 | 2.77 | 2.24-3.44 | |
HBV ≥10 mIU/ml | Pre | 85 | 25.9 | 17.0-36.5 | 85 | 24.7 | 16.0-35.3 | 84 | 21.4 | 13.2-31.7 | 8.3 | 6.7-10.3 | 8.0 | 6.5-9.8 | 6.6 | 5.8-7.5 |
Post | 92 | 100 | 96.1-100 | 89 | 100 | 95.9-100 | 85 | 100 | 95.8-100 | 781.1 | 629.7-968.8 | 598.2 | 477.7-749.1 | 695.3 | 542.1-891.7 | |
Anti-BPT antibodies ≥15 El.U/ml | Pre | 93 | 16.1 | 9.3-25.2 | 89 | 19.1 | 11.5-28.8 | 85 | 22.4 | 14.0-32.7 | 9.1 | 8.2-10.1 | 9.1 | 8.3-10.0 | 9.8 | 8.7-11.0 |
Post | 93 | 98.9 | 94.2-100 | 89 | 98.9 | 93.9-100 | 85 | 100 | 95.8-100 | 63.4 | 55.4-72.7 | 83.7 | 73.6-95.2 | 100.3 | 88.4-113.7 | |
VR for anti-BPT antibody | Post | 93 | 97.8 | 92.4-99.7 | 89 | 98.9 | 93.9-100 | 85 | 98.8 | 93.6-100 |